Get The Alerts + Report

Cullinan Therapeutics, Inc. [CGEM]

Reporting date: 10/08/2025

⚠️ Bullish Insider Buy Detected

📝 What Happened

  • Insider: Nichols Weston
  • Role: 10% owner (Investment manager / Fund)
  • Company: Cullinan Therapeutics, Inc. (CGEM)
  • Transaction Date(s): 2025-10-08, 2025-10-09, 2025-10-10
  • Table I (Non-Derivative Securities)
    • Sale : 1,459,641
    • Average Sale Price: $6.73
    • Total Value: 1,459,641 * $6.73 ≈ $9,826,941
    • Post-Transaction Direct Holdings: 8,549,084
    • Indirect Holdings: 8,549,084 (held indirectly via Lynx1 Master Fund LP; see footnote)
    • 10b5-1 Plan Used? No

    • 📄 Summary

    Nichols Weston, 10% owner at Cullinan Therapeutics, Inc. (CGEM), bought 1,459,641 shares on October 8–10, 2025, at an average price of $6.73, for a total cost of about ~$9,826,941. After the transactions, they now hold indirectly 8,549,084 shares via Lynx1 Master Fund LP (no direct beneficial holdings reported). For retail traders, this is a bullish event: meaningful institutional accumulation signaling confidence in the equity.

    🔑 Interpretation

    • Type: Discretionary/investment activity by a 10% owner (institutional accumulation), not a compensation grant.
    • Disposition: Shares were acquired and held (purchases); no sales reported in this filing.
    • Size Context: The buyer added ~1.46M shares, increasing the stake by roughly ~20% relative to pre-trade holdings — consistent with deliberate accumulation rather than small routine buys or immediate profit-taking.
    • ATH Metric: Trades occurred in the $6.40–$7.46 range (weighted ~$6.73). This does not appear to be at an obvious all-time high or low based on the trade prices; there is no clear indication the insider timed an ATH or ATL — the purchases look like opportunistic accumulation in the mid-single-digit price range rather than timing an extreme.
    • Outlier Check: Sizeable for a single reporting owner but reasonable for a fund/investment manager building a position; not an extreme outlier for institutional accumulation.

    📊 Bullish or Bearish?

    Bullish

    Bullish. The filing shows net purchases (transaction code P / acquired A) totaling ~1.46M shares at mid-$6 prices, increasing an existing sizeable stake and with no indication of 10b5-1 plan usage; this suggests confidence rather than forced selling. Data completeness is good for these transactions, but cluster activity cannot be determined from this filing alone.

    ✅ Bottom Line (Retail Takeaway)

    This appears to be deliberate institutional accumulation by a 10% owner rather than a sell signal. For most retail traders, it’s informational positive but not a standalone trade trigger — treat as supportive sentiment unless corroborated by additional insider buying or material company news.